Mariner’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$3.25M Buy
59,131
+25,476
+76% +$1.4M ﹤0.01% 1062
2025
Q1
$2.38M Buy
33,655
+6,378
+23% +$451K ﹤0.01% 1147
2024
Q4
$1.79M Buy
27,277
+10,527
+63% +$692K ﹤0.01% 1276
2024
Q3
$1.18M Sell
16,750
-5,430
-24% -$382K ﹤0.01% 1483
2024
Q2
$1.83M Sell
22,180
-2,542
-10% -$209K ﹤0.01% 1157
2024
Q1
$2.16M Sell
24,722
-2,748
-10% -$240K ﹤0.01% 1069
2023
Q4
$2.65M Sell
27,470
-21
-0.1% -$2.03K 0.01% 934
2023
Q3
$2.43M Buy
27,491
+2,336
+9% +$207K 0.01% 898
2023
Q2
$2.18M Buy
25,155
+2,321
+10% +$201K 0.01% 935
2023
Q1
$2.22M Sell
22,834
-2,365
-9% -$230K 0.01% 912
2022
Q4
$2.61M Sell
25,199
-303
-1% -$31.4K 0.01% 818
2022
Q3
$2.16M Buy
25,502
+58
+0.2% +$4.92K 0.01% 740
2022
Q2
$2.11M Buy
25,444
+1,384
+6% +$115K 0.01% 694
2022
Q1
$1.86M Buy
24,060
+4,313
+22% +$333K 0.01% 740
2021
Q4
$1.75M Buy
19,747
+7,168
+57% +$633K 0.01% 688
2021
Q3
$972K Sell
12,579
-3,398
-21% -$263K 0.01% 709
2021
Q2
$1.33M Sell
15,977
-701
-4% -$58.5K 0.01% 596
2021
Q1
$1.26M Sell
16,678
-8,629
-34% -$651K 0.01% 559
2020
Q4
$2.22M Buy
25,307
+9,919
+64% +$870K 0.02% 416
2020
Q3
$1.17M Buy
15,388
+7
+0% +$533 0.01% 471
2020
Q2
$1.9M Buy
15,381
+429
+3% +$52.9K 0.02% 386
2020
Q1
$1.26M Sell
14,952
-2,623
-15% -$222K 0.02% 440
2019
Q4
$1.49M Buy
17,575
+649
+4% +$54.9K 0.02% 436
2019
Q3
$1.14M Buy
16,926
+2,223
+15% +$150K 0.01% 455
2019
Q2
$1.26M Buy
14,703
+2,176
+17% +$186K 0.02% 486
2019
Q1
$1.11M Buy
12,527
+8
+0.1% +$711 0.02% 469
2018
Q4
$1.07M Buy
12,519
+100
+0.8% +$8.52K 0.02% 422
2018
Q3
$1.2M Sell
12,419
-400
-3% -$38.8K 0.03% 369
2018
Q2
$1.21M Buy
12,819
+1,042
+9% +$98.2K 0.03% 365
2018
Q1
$955K Sell
11,777
-755
-6% -$61.2K 0.03% 320
2017
Q4
$1.12M Buy
+12,532
New +$1.12M 0.04% 271